Table 4.

Average change in BP from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having BP>140/90 mm Hg despite prescribed antihypertensive medications who had systolic hypertension at baseline

	Average change in BP from baseline to 1 month		Average change in BP from baseline to 2 months		Average change in BP from baseline to 3 months
	Intervention (n=64)	Controls (n=18)	Intervention (n=64)	Controls (n=27)	Intervention (n=60)	Controls (n=24)
Systolic (95% CI) (range)	−15.00* (−18.51 to −11.49) (−57 to +18)†	−6.50 (−14.67 to +1.67) (−36 to +27)	−16.37* (−20.42 to −12.33) (−60 to +23)†	−7.82 (−15.74 to +0.11) (−38 to +28)	−15.88* (−19.96 to −11.81) (−61 to +18)	−11.42* (−17.96 to −4.87) (−47 to +16)
Diastolic (95% CI) (range)	−1.78 (−4.19 to +0.63) (−22 to +19)	−4.00 (−8.35 to +0.35) (−21 to +14)	−2.89* (−5.60 to −0.19) (−24 to +19)	−4.19* (−7.68 to −0.69) (−21 to +15)	−3.08* (−5.77 to −0.40) (−23 to +21)	−2.67 (−7.18 to +1.84) (−32 to +18)
	Average change in BP from baseline to 4 months		Average change in BP from baseline to 5 months		Average change in BP from baseline to 6 months
	Intervention (n=20)	Controls (n=26)	Intervention (n=15)	Controls (n=22)	Intervention (n=14)	Controls (n=12)
Systolic (95% CI) (range)	−10.25* (−18.53 to −1.97) (−54 to +25)	−8.69* (−13.91 to −3.48) (−37 to +15)	−10.87* (−19.56 to −2.18) (−30 to +18)	−3.09 (−10.02 to +3.84) (−33 to +31)	−12.57* (−19.03 to −6.11) (−36 to +6)	−2.42 (−13.95 to +9.12) (−40 to +25)
Diastolic (95% CI) (range)	+0.45 (−4.85 to +5.75) (−29 to +24)	−3.27 (−7.59 to +1.05) (−27 to +18)	−1.67 (−7.73 to +4.39) (−15 to +22)	−4.09* (−8.92 to +0.74) (−24 to +17)	−3.36 (−7.91 to +1.20) (−15 to +17)	−0.17 (−6.28 to +6.62) (−21 to +19)

*Change in BP from baseline to time point in programme significant at the level of p<0.05.

†Difference in change in BP between intervention and control patients significant at the level of p<0.05.

BP, blood pressure.